Key facts
- Browndove Healthcare’s last known valuation is $13.6M (May 2019).
- It has raised $6.5M; the latest was PE Growth/Expansion in Apr 2025.
- Notable investors include Somerset Indus Capital Partners, Tranzmute Capital & Management.
- Status: Privately Held (backing).
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Browndove Healthcare
- ·The full record, as it builds
Funding rounds
No funding rounds for Browndove Healthcare are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Browndove Healthcare
Manufacturer of dialysis medical devices intended to serve the renal care community. The company's products include a blood tubing set, dialyzer, AV fistula needle, transducer protector, sodium chloride and dialysate mixer with the support of machinery, sterilization, testing lab and storage facilities, enabling hospitals to improve their renal care unit.
- Sector
- Healthcare
- HQ
- Bengaluru, India
- Founded
- 1996
- Employees
- 133
- Website
- browndove.com/
- Ownership
- Privately Held (backing)
Browndove Healthcare doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Browndove Healthcare shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Browndove Healthcare in its N-PORT filings yet. We sweep new filings monthly.